Adverse side effects of recently approved Alzheimer’s therapy, lecanemab, are ‘manageable', reported a new study published in JAMA Neurology. The findings may inform discussions about the risks of ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. One of neurologist Anelyssa D’Abreu’s least ...

Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne (galantamine)—is expected to be available in U.S. pharmacies by the end of March. The drug was approved by the ...

The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Alzheimer’s disease medicines typically help reduce and manage symptoms. They do not treat the cause of Alzheimer’s disease. Kisunla offers a new approach to treat early Alzheimer’s disease. It ...

To learn more about the drug’s serious side effects, talk with your doctor or see donepezil’s prescribing information. The side effects of donepezil are generally the same regardless of age. But ...

Antidepressants can be very effective, but they also come with side effects that vary from one drug to the next, supporting ...